- Bezpečnost a účinnost vemurafenibu u pacientů s maligním melanomem s mutacemi BRAF V600E a BRAF V600K - prodloužené sledování studie BRIM-32014 | Publikace bez příslušnosti k fakultě
- Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine A2014 | 1. lékařská fakulta, 3. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy2022 | 1. lékařská fakulta, 3. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study2023 | 1. lékařská fakulta
- Povolání a riziko karcinomu horní části zažívacího traktu: studie ARCAGE2012 | 1. lékařská fakulta
- CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group2011 | 1. lékařská fakulta
- Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study2019 | Lékařská fakulta v Hradci Králové
- Resolute zotarolimus-eluting coronary stent system for the treatment of coronary artery disease2014 | 3. lékařská fakulta
- Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study2020 | 1. lékařská fakulta
- Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants2021 | Publikace bez příslušnosti k fakultě
- Recurrent YAP1-TFE3 Gene Fusions in Clear Cell Stromal Tumor of the Lung2021 | Lékařská fakulta v Plzni
- Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial2023 | 1. lékařská fakulta